Stock Quote

Cincinnati biopharma startup lands massive $143M round

A Cincinnati company developing treatments for diseases like hypertension and more has raised a $143 million Series B — the second startup in the region to land a nine-figure fund raise so far this year.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.